South East Asia / Product Areas / Vascular Access

Browse our Vascular Access Products / South East Asia Non-Direct Sales Countries (change)

About Arrow from Teleflex

We are a global leader focused on reducing vascular-related complications through world-class solutions designed to equally benefit clinicians and patients. Our goal is to provide intuitive products and consultative programs that improve procedural efficiencies, patient outcomes, and healthcare economic value to advance care in Vascular Access.

Customer Support - Singapore

Teleflex Medical Asia Pte. Ltd.

83 Clemenceau Avenue #05-05-08 UE Square East Wing Singapore 23992 Phone: +65 6439 3000 Fax: +65 6438 2380 Email Teleflex Medical Asia

Rx only

Contraindication: The Arrowg+ard Blue Plus CVC is contraindicated for patients with known hypersensitivity to chlorhexidine and silver sulfadiazine and/or sulfa drugs.

Contraindication: Clinical assessment of the patient must be completed to ensure no contraindications exist. The Arrowg+ard Blue Advance PICC is contraindicated in the following areas:
• Patients with known hypersensitivity to chlorhexidine
• In presence of device related infections
• In presence of previous or current thrombosis in the intended vessel or along the catheterized vessel pathway.

No correlation between in vitro/in vivo testing methods and clinical outcomes have currently been ascertained.

Teleflex, the Teleflex logo, Arrow, Arrowg+ard Blue Advance, Arrowg+ard Blue Plus, and Endurance are trademarks or registered trademarks of Teleflex Incorporated or its affiliates, in the U.S. and/or other countries. All other trademarks are trademarks of their respective owners. MCI-2020-0426